Noxafil and Gemfibrozil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Noxafil (posaconazole) and Gemfibrozil (gemfibrozil). Common drug interactions include abdominal discomfort among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Noxafil and Gemfibrozil. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Noxafil?

Noxafil has active ingredients of posaconazole. eHealthMe is studying from 5,919 Noxafil users. Check the latest studies of Noxafil.

What is Gemfibrozil?

Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 18,213 Gemfibrozil users. Check the latest studies of Gemfibrozil.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

11 people who take Noxafil and Gemfibrozil together, and have interactions are studied.

Noxafil and Gemfibrozil drug interactions.

What are the common drug interactions of Noxafil and Gemfibrozil, by gender? *:

female:

Abdominal discomfort
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Dysphonia (speech disorder attributable to a disorder of phonation)
Malaise (a feeling of general discomfort or uneasiness)
Pulmonary mycosis (lung infection caused by yeast-like fungi)
Secretion discharge
Fatigue (feeling of tiredness)
Adverse event
Headache (pain in head)
Hepatitis acute

male:

Abdominal distension
Blood creatinine increased
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Glomerular filtration rate decreased
Glossodynia (a burning or painful sensation in the tongue)
Hypokalaemia (low potassium)
Myalgia (muscle pain)
Nausea (feeling of having an urge to vomit)
Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
Oedema peripheral (superficial swelling)

What are the common drug interactions of Noxafil and Gemfibrozil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Fatigue (feeling of tiredness)
Headache (pain in head)
Hepatitis acute

60+:

Abdominal discomfort
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Blood urea increased
Diarrhoea
Dysgeusia (disorder of the sense of taste)
Dyspepsia (indigestion)
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Glomerular filtration rate decreased

What are the existing conditions these people have? *

Immunodeficiency: 2 people, 18.18%
Renal Cell Carcinoma (a kidney cancer): 1 person, 9.09%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 9.09%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 9.09%
Constipation: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Noxafil and Gemfibrozil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously